114 related articles for article (PubMed ID: 9342632)
1. Detection of the circulating lung cancer marker LCAP with a new monoclonal antibody TRD-L1.
Tsuji K; Uwano T; Yoshida Y; Kikuchi K; Okamoto T; Yamamoto S; Ichiki M; Hayashi I; Ohno T; Kufe DW
Int J Biol Markers; 1997; 12(2):49-54. PubMed ID: 9342632
[TBL] [Abstract][Full Text] [Related]
2. Lung cancer-associated protein: development and characterization of a new assay that detects a circulating lung cancer marker.
Maimonis P; Hayes DF; Schaffel S; Kufe D
Cancer Res; 1991 Aug; 51(15):3838-42. PubMed ID: 1855201
[TBL] [Abstract][Full Text] [Related]
3. Difference in sero-diagnostic values among KL-6-associated mucins classified as cluster 9.
Kohno N; Inoue Y; Hamada H; Fujioka S; Fujino S; Yokoyama A; Hiwada K; Ueda N; Akiyama M
Int J Cancer Suppl; 1994; 8():81-3. PubMed ID: 8194900
[TBL] [Abstract][Full Text] [Related]
4. CYFRA 21-1 enzyme-linked immunosorbent assay. Evaluation as a tumor marker in non-small cell lung cancer.
Lai RS; Hsu HK; Lu JY; Ger LP; Lai NS
Chest; 1996 Apr; 109(4):995-1000. PubMed ID: 8635383
[TBL] [Abstract][Full Text] [Related]
5. Prospective study on the diagnosis and prognosis of lung cancer by using new simultaneously observed seromarkers.
Zhang Q; Ren H; Wang B
Ann N Y Acad Sci; 1995 Sep; 768():337-40. PubMed ID: 8526382
[No Abstract] [Full Text] [Related]
6. A new serum tumor marker, CAM 123-6, highly specific to pulmonary adenocarcinoma.
Hamada H; Kohno N; Hiwada K
Jpn J Cancer Res; 1994 Feb; 85(2):211-9. PubMed ID: 8144402
[TBL] [Abstract][Full Text] [Related]
7. Detection of a circulating tumor-associated antigen with a murine monoclonal antibody, LISA 101, selected by reversed indirect enzyme-linked immunosorbent assay.
Kohno N; Kyoizumi S; Tanabe M; Oyama T; Vossler M; Yamakido M; Akiyama M
Cancer Res; 1989 Jun; 49(12):3412-9. PubMed ID: 2655895
[TBL] [Abstract][Full Text] [Related]
8. The oncogenetic role of stanniocalcin 1 in lung adenocarcinoma: a promising serum candidate biomarker for tracking lung adenocarcinoma progression.
Du YZ; Gu XH; Cheng SF; Li L; Liu H; Hu LP; Gao F
Tumour Biol; 2016 Apr; 37(4):5633-44. PubMed ID: 26577859
[TBL] [Abstract][Full Text] [Related]
9. Enzyme-linked immunosorbent assay of pro-gastrin-releasing peptide for small cell lung cancer patients in comparison with neuron-specific enolase measurement.
Yamaguchi K; Aoyagi K; Urakami K; Fukutani T; Maki N; Yamamoto S; Otsubo K; Miyake Y; Kodama T
Jpn J Cancer Res; 1995 Jul; 86(7):698-705. PubMed ID: 7559089
[TBL] [Abstract][Full Text] [Related]
10. Development of an AlphaLISA assay to quantify serum core-fucosylated E-cadherin as a metastatic lung adenocarcinoma biomarker.
Wen CL; Chen KY; Chen CT; Chuang JG; Yang PC; Chow LP
J Proteomics; 2012 Jul; 75(13):3963-76. PubMed ID: 22634079
[TBL] [Abstract][Full Text] [Related]
11. Serum levels and biochemical characteristics of human ovarian carcinoma-associated antigen defined by murine monoclonal antibody, CF511.
Ohkawa K; Tsukada Y; Murae M; Kimura E; Takada K; Abe T; Terashima Y; Mitani K
Br J Cancer; 1989 Dec; 60(6):953-60. PubMed ID: 2605105
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibody-mediated detection of lung cancer antigens in serum.
Schepart BS; Margolis ML
Am Rev Respir Dis; 1988 Dec; 138(6):1434-8. PubMed ID: 3059895
[TBL] [Abstract][Full Text] [Related]
13. Are circulating autoantibodies to ABCC3 transporter a potential biomarker for lung cancer?
Liu L; Liu N; Liu B; Yang Y; Zhang Q; Zhang W; Yu P; Jin Y; Guo J; Guan S; Sun S; Miao L; Wei J
J Cancer Res Clin Oncol; 2012 Oct; 138(10):1737-42. PubMed ID: 22699933
[TBL] [Abstract][Full Text] [Related]
14. Detection of a novel lung adenocarcinoma--associated serum antigen defined by two monoclonal antibodies, KM 432 and KM 227.
Shitara K; Hanai N; Yoshida H
Anticancer Res; 1993; 13(3):579-86. PubMed ID: 7686360
[TBL] [Abstract][Full Text] [Related]
15. Fine tuning of epitopic dominance induced by lung cancer on the IgG response to bovine betalactoglobulin: towards a paraneoplastic immune marker.
Michils A; Lambert JP; Yernault JC; Fabry V; Gossart B; Duchateau J
Cancer; 1996 Feb; 77(4):657-64. PubMed ID: 8616757
[TBL] [Abstract][Full Text] [Related]
16. SPLUNC1 Is a Significant Marker in Pleural Effusion from Lung Cancer Compared to Tuberculosis.
Xue JL; Yi L; Yan ZH; Li X; Wang XJ; Wei PJ; Zeng JE; Zhao YL; Zhang HT
Monoclon Antib Immunodiagn Immunother; 2015 Jun; 34(3):206-12. PubMed ID: 26090599
[TBL] [Abstract][Full Text] [Related]
17. Detection and characterization of a high molecular weight human lung carcinoma-associated glycoprotein.
Maimonis P; Hayes DF; O'Hara C; Kufe D
Cancer Res; 1990 Oct; 50(20):6738-43. PubMed ID: 1698541
[TBL] [Abstract][Full Text] [Related]
18. Serum AGR2 as an early diagnostic and postoperative prognostic biomarker of human lung adenocarcinoma.
Chung K; Nishiyama N; Yamano S; Komatsu H; Hanada S; Wei M; Wanibuchi H; Suehiro S; Kakehashi A
Cancer Biomark; 2011-2012; 10(2):101-7. PubMed ID: 22430137
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Annexin A2 as a novel diagnostic serum biomarker for lung cancer.
Yang J; Yang F; Nie J; Zou X; Tian H; Qin Y; Liu C
Cancer Biomark; 2015; 15(2):205-11. PubMed ID: 25519022
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibody KP16D3 as a prognostic marker in stage I lung adenocarcinoma.
Suehiro T; Ishida T; Sugio K; Sugimachi K; Sueishi K
J Surg Oncol; 1993 Sep; 54(1):51-6. PubMed ID: 8377507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
